Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA
Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS ( Dr Wungki Park - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jul 2026

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas ( Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan )
6 Jul 2026

Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma

Dr Peter Voorhees - Atrium Health Levine Cancer Institute, Charlotte, USA
Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma ( Dr Peter Voorhees - Atrium Health Levine Cancer Institute, Charlotte, USA )
3 Jul 2026

Defining breast cancer quality care around the globe

Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman
Defining breast cancer quality care around the globe ( Dr Didier Verhoeven, Prof Sabine Siesling, Prof Pankaj Gupta Roy & Prof Cary Kaufman )
1 Jul 2026

Global oncology innovations: B.J. Kennedy award for geriatric oncology

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA
Global oncology innovations: B.J. Kennedy award for geriatric oncology ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )
30 Jun 2026

Global disparities in cancer care for conflict-affected populations: Africa's neglected crisis

Prof Nazik Hammad - University of Toronto, Toronto, Canada
Global disparities in cancer care for conflict-affected populations: Africa's neglected crisis ( Prof Nazik Hammad - University of Toronto, Toronto, Canada )
30 Jun 2026

Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC

Dr Rahul Aggarwal - University of California, San Francisco, USA
Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC ( Dr Rahul Aggarwal - University of California, San Francisco, USA )
26 Jun 2026

The evolving treatment landscape in immune thrombocytopenia

Dr Hanny Al-Samkari - Massachusetts General Hospital, Boston, USA
The evolving treatment landscape in immune thrombocytopenia ( Dr Hanny Al-Samkari - Massachusetts General Hospital, Boston, USA )
25 Jun 2026

Highlights from APCCC 2026

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
Highlights from APCCC 2026 ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
24 Jun 2026

ASCO 2026: Updates in bladder cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
ASCO 2026: Updates in bladder cancer ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
24 Jun 2026

ASCO 2026: Updates in renal cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
ASCO 2026: Updates in renal cancer ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
23 Jun 2026

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
22 Jun 2026